2021
|
Invention
|
Compositions and methods for treatment of coronavirus infection. Compounds and methods for the tr... |
|
Invention
|
Aminopyridine compounds and methods for the preparation and use thereof.
The present invention r... |
2020
|
Invention
|
Arginine gingipain inhibitors.
Therapeutics targeting the bacterium Porphyromonas gingivalis, in... |
|
Invention
|
Arginine gingipain inhibitors. Therapeutics targeting the bacterium Porphyromonas gingivalis, inc... |
|
Invention
|
Arginine gingipain inhibitors. Porphyromonas gingivalisP. gingivalisP. gingivalis infection, incl... |
2019
|
Invention
|
Methods for detection of microbial nucleic acids in body fluids.
Methods for detecting microbial... |
|
Invention
|
Methods for detection of microbial nucleic acids in body fluids. Porphyromonas gingivalis, e.g.Po... |
2018
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of Alzheimer's, brain disorders, neu... |
|
Invention
|
Aminopyridine compounds and methods for the preparation and use thereof. The present invention re... |
|
Invention
|
Aminopyridine compounds and methods for the preparation and use thereof. The present invent... |
2017
|
Invention
|
Ketone inhibitors of lysine gingipain. The present invention provides compounds according to Form... |
|
Invention
|
Treatment of osteoarthritis with gingipain blocking agents. The invention provides methods for tr... |
2016
|
Invention
|
Inhibitors of arginine gingipain. The present invention relates generally to therapeutics targeti... |
2015
|
Invention
|
Inhibitors of lysine gingipain. The present invention relates generally to therapeutics targeting... |
|
Invention
|
Methods of use for therapeutics targeting the pathogen porphyromonas gingivalis.
The invention r... |